Review




Structured Review

Aries Pharmaceuticals Inc aemcolo (rifamycin sv)
Key attributes, physiochemical properties, and PK parameters [ <xref ref-type= 32 , 33 ] of FDA-approved macrocyclic drugs since 2014." width="250" height="auto" />
Aemcolo (Rifamycin Sv), supplied by Aries Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aemcolo (rifamycin sv)/product/Aries Pharmaceuticals Inc
Average 90 stars, based on 1 article reviews
aemcolo (rifamycin sv) - by Bioz Stars, 2026-02
90/100 stars

Images

1) Product Images from "Recent Advances in Macrocyclic Drugs and Microwave-Assisted and/or Solid-Supported Synthesis of Macrocycles"

Article Title: Recent Advances in Macrocyclic Drugs and Microwave-Assisted and/or Solid-Supported Synthesis of Macrocycles

Journal: Molecules

doi: 10.3390/molecules27031012

Key attributes, physiochemical properties, and PK parameters [ <xref ref-type= 32 , 33 ] of FDA-approved macrocyclic drugs since 2014." title="Key attributes, physiochemical properties, and PK parameters [32,33] of FDA-approved macrocyclic drugs since ... " property="contentUrl" width="100%" height="100%"/>
Figure Legend Snippet: Key attributes, physiochemical properties, and PK parameters [ 32 , 33 ] of FDA-approved macrocyclic drugs since 2014.

Techniques Used: Protein Binding, Protease Inhibitor, Inhibition, Disruption, Membrane, Binding Assay, Clinical Proteomics, Control, Diagnostic Assay, Imaging



Similar Products

90
Aries Pharmaceuticals Inc aemcolo (rifamycin sv)
Key attributes, physiochemical properties, and PK parameters [ <xref ref-type= 32 , 33 ] of FDA-approved macrocyclic drugs since 2014." width="250" height="auto" />
Aemcolo (Rifamycin Sv), supplied by Aries Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aemcolo (rifamycin sv)/product/Aries Pharmaceuticals Inc
Average 90 stars, based on 1 article reviews
aemcolo (rifamycin sv) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Key attributes, physiochemical properties, and PK parameters [ <xref ref-type= 32 , 33 ] of FDA-approved macrocyclic drugs since 2014." width="100%" height="100%">

Journal: Molecules

Article Title: Recent Advances in Macrocyclic Drugs and Microwave-Assisted and/or Solid-Supported Synthesis of Macrocycles

doi: 10.3390/molecules27031012

Figure Lengend Snippet: Key attributes, physiochemical properties, and PK parameters [ 32 , 33 ] of FDA-approved macrocyclic drugs since 2014.

Article Snippet: Aemcolo (rifamycin SV) , Antibacterial , Protein synthesis inhibitor by binding to the β-subunit of bacterial DNA-dependent RNA polymerase , 697.77 , 1.52 , 13 , 6 , 201 , 388 mg (two tablets) PO twice daily , , <0.1 , 80 , , Not expected , , 86 , Aries Pharmaceuticals, Inc. , 16 November 2018.

Techniques: Protein Binding, Protease Inhibitor, Inhibition, Disruption, Membrane, Binding Assay, Clinical Proteomics, Control, Diagnostic Assay, Imaging